• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值作为真性红细胞增多症患者死亡率的预后指标:前瞻性队列分析的见解。

Neutrophil-to-lymphocyte ratio as a prognostic indicator of mortality in Polycythemia Vera: insights from a prospective cohort analysis.

机构信息

FROM, Fondazione per la Ricerca Ospedale di Bergamo ETS, Bergamo, Italy.

Dipartimento di Scienze Mediche e Chirurgiche, Materno-Infantili e dell'Adulto, Università di Modena-Reggio Emilia, Modena, Italy.

出版信息

Blood Cancer J. 2024 Nov 6;14(1):195. doi: 10.1038/s41408-024-01176-7.

DOI:10.1038/s41408-024-01176-7
PMID:39505848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11541874/
Abstract

We analyzed the neutrophil-to-lymphocyte ratio (NLR) in 1508 patients with PV and found that those with an NLR ≥ 5 were generally older, had a longer disease history, and had higher cardiovascular risk factors, more arterial thrombosis, and more aggressive blood counts, indicating a more proliferative disease. NLR was an accurate predictor of mortality, with patients with NLR ≥ 5 having significantly worse overall survival and more than twice the mortality rate compared to those with NLR < 5. Multivariable models confirmed that increasing age, previous venous thrombosis and NLR ≥ 5 were strong predictors of death, further influenced by cardiovascular risk factors. We examined the interaction between NLR and the number of cardiovascular risk factors and found a progressive trend of increased mortality risk for NLR values ≥ 5 in addition to the presence of more than one risk factor. In conclusion, patients with NLR ≥ 5 require careful monitoring and management of cardiovascular risk factors because they increase mortality when associated with progressive levels of NLR.

摘要

我们分析了 1508 例 PV 患者的中性粒细胞与淋巴细胞比值(NLR),发现 NLR≥5 的患者通常年龄较大,疾病史较长,心血管危险因素较高,动脉血栓形成较多,血液计数更具侵袭性,表明疾病更具增生性。NLR 是死亡率的准确预测指标,NLR≥5 的患者总生存率明显较差,死亡率是 NLR<5 的患者的两倍多。多变量模型证实,年龄增长、既往静脉血栓形成和 NLR≥5 是死亡的强烈预测因素,进一步受心血管危险因素的影响。我们检查了 NLR 与心血管危险因素数量之间的相互作用,发现 NLR 值≥5 除了存在一个以上危险因素外,与死亡率风险增加呈正相关。总之,NLR≥5 的患者需要仔细监测和管理心血管危险因素,因为它们与 NLR 的逐渐升高水平相关联会增加死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/11541874/a3256dd7b77a/41408_2024_1176_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/11541874/38629382ca20/41408_2024_1176_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/11541874/f5763d372d2c/41408_2024_1176_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/11541874/a3256dd7b77a/41408_2024_1176_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/11541874/38629382ca20/41408_2024_1176_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/11541874/f5763d372d2c/41408_2024_1176_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e43/11541874/a3256dd7b77a/41408_2024_1176_Fig3_HTML.jpg

相似文献

1
Neutrophil-to-lymphocyte ratio as a prognostic indicator of mortality in Polycythemia Vera: insights from a prospective cohort analysis.中性粒细胞与淋巴细胞比值作为真性红细胞增多症患者死亡率的预后指标:前瞻性队列分析的见解。
Blood Cancer J. 2024 Nov 6;14(1):195. doi: 10.1038/s41408-024-01176-7.
2
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera.中性粒细胞与淋巴细胞比值是真性红细胞增多症静脉血栓形成的新预测因子。
Blood Cancer J. 2022 Feb 10;12(2):28. doi: 10.1038/s41408-022-00625-5.
3
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as novel prognostic biomarkers in BCR-ABL negative myeloproliferative neoplasms.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值作为 BCR-ABL 阴性骨髓增殖性肿瘤的新型预后生物标志物。
Ann Hematol. 2024 Nov;103(11):4545-4556. doi: 10.1007/s00277-024-06023-0. Epub 2024 Sep 27.
4
The Predictive Value of Neutrophil-Lymphocyte Ratio in Patients with Polycythemia Vera at the Time of Initial Diagnosis for Thrombotic Events.中性粒细胞-淋巴细胞比值对初诊时血栓事件的预测价值。
Biomed Res Int. 2022 Aug 8;2022:9343951. doi: 10.1155/2022/9343951. eCollection 2022.
5
Association of neutrophil-lymphocyte ratio with all-cause and cardiovascular mortality in US adults with diabetes and prediabetes: a prospective cohort study.中性粒细胞与淋巴细胞比值与美国糖尿病和糖尿病前期成人全因和心血管死亡率的关系:一项前瞻性队列研究。
BMC Endocr Disord. 2024 May 10;24(1):64. doi: 10.1186/s12902-024-01592-7.
6
Neutrophil-lymphocyte ratio as a novel predictor of survival in chronic hemodialysis patients.中性粒细胞与淋巴细胞比值作为慢性血液透析患者生存的新型预测指标。
Clin Nephrol. 2016 Apr;85(4):191-8. doi: 10.5414/CN108745.
7
Neutrophil-to-lymphocyte ratio predicts long-term all-cause mortality in patients with chronic kidney disease stage 5.中性粒细胞与淋巴细胞比值可预测5期慢性肾脏病患者的长期全因死亡率。
Folia Med Cracov. 2019;59(4):55-70. doi: 10.24425/fmc.2019.131380.
8
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Effective Predictors of Prognosis in Patients with Acute Mesenteric Arterial Embolism and Thrombosis.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值是急性肠系膜动脉栓塞和血栓形成患者预后的有效预测指标。
Ann Vasc Surg. 2018 May;49:115-122. doi: 10.1016/j.avsg.2018.01.059. Epub 2018 Feb 9.
9
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of survival after heart transplantation.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值可预测心脏移植后的生存率。
ESC Heart Fail. 2018 Feb;5(1):149-156. doi: 10.1002/ehf2.12199. Epub 2017 Jul 31.
10
Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.血液中性粒细胞与淋巴细胞比值升高:一种与高危非转移性黑色素瘤疾病死亡相关的便捷生物标志物。
Ann Surg Oncol. 2017 Jul;24(7):1989-1996. doi: 10.1245/s10434-017-5836-0. Epub 2017 Mar 16.

引用本文的文献

1
Neutrophil-to-Lymphocyte ratio as surrogate for JAK2 suppression and event-free survival in polycythemia vera.中性粒细胞与淋巴细胞比值作为真性红细胞增多症中JAK2抑制和无事件生存期的替代指标。
Blood Cancer J. 2025 Aug 6;15(1):132. doi: 10.1038/s41408-025-01317-6.
2
Association between pan-immune-inflammation value and coronary heart disease in elderly population: a cross-sectional study.老年人群全免疫炎症值与冠心病的关联:一项横断面研究
Front Cardiovasc Med. 2025 Feb 10;12:1538643. doi: 10.3389/fcvm.2025.1538643. eCollection 2025.
3
Therapeutic Black Phosphorus Nanosheets Elicit Neutrophil Response for Enhanced Tumor Suppression.

本文引用的文献

1
Neutrophil/lymphocyte ratio identifies low-risk polycythaemia vera patients for early Ropeginterferon alfa-2b therapy.中性粒细胞/淋巴细胞比值可识别低风险真性红细胞增多症患者以便早期使用聚乙二醇干扰素α-2b治疗。
Br J Haematol. 2024 Dec;205(6):2287-2294. doi: 10.1111/bjh.19813. Epub 2024 Oct 7.
2
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera.罗沙司他,一种促红细胞生成素类似物,用于控制真性红细胞增多症的红细胞增多。
N Engl J Med. 2024 Feb 22;390(8):723-735. doi: 10.1056/NEJMoa2308809.
3
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study.
治疗性黑磷纳米片引发中性粒细胞反应以增强肿瘤抑制作用。
Adv Sci (Weinh). 2025 Apr;12(14):e2414779. doi: 10.1002/advs.202414779. Epub 2025 Jan 22.
中性粒细胞与淋巴细胞比值与有无骨髓增生性肿瘤患者的全因死亡率:一项丹麦纵向研究。
Blood Cancer J. 2024 Feb 9;14(1):28. doi: 10.1038/s41408-024-00994-z.
4
Moving toward disease modification in polycythemia vera.向真性红细胞增多症的疾病修饰治疗迈进。
Blood. 2023 Nov 30;142(22):1859-1870. doi: 10.1182/blood.2023021503.
5
Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management.真性红细胞增多症:2024 年诊断、风险分层和治疗更新。
Am J Hematol. 2023 Sep;98(9):1465-1487. doi: 10.1002/ajh.27002. Epub 2023 Jun 26.
6
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.芦可替尼与最佳可用疗法治疗不耐受或对羟基脲耐药的真性红细胞增多症的随机试验。
J Clin Oncol. 2023 Jul 1;41(19):3534-3544. doi: 10.1200/JCO.22.01935. Epub 2023 May 1.
7
Excess mortality in younger patients with myeloproliferative neoplasms.骨髓增殖性肿瘤年轻患者的超额死亡率。
Leuk Lymphoma. 2023 Mar;64(3):725-729. doi: 10.1080/10428194.2022.2070914. Epub 2022 May 9.
8
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera.中性粒细胞与淋巴细胞比值是真性红细胞增多症静脉血栓形成的新预测因子。
Blood Cancer J. 2022 Feb 10;12(2):28. doi: 10.1038/s41408-022-00625-5.
9
Inflammation-Induced Tumorigenesis and Metastasis.炎症诱导的肿瘤发生和转移。
Int J Mol Sci. 2021 May 21;22(11):5421. doi: 10.3390/ijms22115421.
10
Impact of Host, Lifestyle and Environmental Factors in the Pathogenesis of MPN.宿主、生活方式和环境因素在骨髓增殖性肿瘤发病机制中的作用
Cancers (Basel). 2020 Jul 24;12(8):2038. doi: 10.3390/cancers12082038.